Jump to Content Jump to Main Navigation

Volume 15 (2017): Issue 8 (Aug 2017)

in Journal of the National Comprehensive Cancer Network

Online ISSN:: 1540-1413

Print ISSN:: 1540-1405

NCCN News

Pages: xxvii–xxix
Oncology Research Program

Pages: xxxv–xxxvi
When It's Really Good, We Know It!

By: Margaret Tempero

Pages: 973
To the Editor: How Do We Solve This Confusion?

Pages: 975–976
Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas

By: Anastasia Drobysheva, Laura J. Klesse, Daniel C. Bowers, Veena Rajaram, Dinesh Rakheja, Charles F. Timmons, Jason Wang, Korgun Koral, Lynn Gargan, Erica Ramos and Jason Y. Park

Pages: 978–982
Neoadjuvant Treatment With Trastuzumab and FOLFOX Induces a Complete Pathologic Response in a Metastatic ERBB2 (HER2)-Amplified Duodenal Cancer

By: Ahmad Hamad, Aatur D. Singhi, Nathan Bahary, Kevin McGrath, Rula Amarin, Herbert J. Zeh and Amer H. Zureikat

Pages: 983–988
NCCN Guidelines Insights: Palliative Care, Version 2.2017

By: Maria Dans, Thomas Smith, Anthony Back, Justin N. Baker, Jessica R. Bauman, Anna C. Beck, Susan Block, Toby Campbell, Amy A. Case, Shalini Dalal, Howard Edwards, Thomas R. Fitch, Jennifer Kapo, Jean S. Kutner, Elizabeth Kvale, Charles Miller, Sumathi Misra, William Mitchell, Diane G. Portman, David Spiegel, Linda Sutton, Eytan Szmuilowicz, Jennifer Temel, Roma Tickoo, Susan G. Urba, Elizabeth Weinstein, Finly Zachariah, Mary Anne Bergman and Jillian L. Scavone

Pages: 989–997
Race- and Sex-Based Disparities in the Therapy and Outcomes of Squamous Cell Carcinoma of the Anus

By: Nivedita Arora, Arjun Gupta, Hong Zhu, Alana Christie, Jeffrey J. Meyer, Saad A. Khan and Muhammad S. Beg

Pages: 998–1004
The Evolution of Metastatic Colorectal Cancer Clinical Trials: Application of the ASCO Framework for Assessing Value

By: Doreen A. Ezeife, Sunil Parimi, Ellen R. Cusano, Matthew K. Smith, Tony H. Truong, Soundouss Raissouni, Yongtao Lin, Jose G. Monzon, Haocheng Li, Vincent C. Tam and Patricia A. Tang

Pages: 1005–1013
Costs and Benefits of Extended Endocrine Strategies for Premenopausal Breast Cancer

By: Janice S. Kwon, Gary Pansegrau, Melica Nourmoussavi, Geoffrey L. Hammond and Mark S. Carey

Pages: 1015–1021
Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993–2013

By: Talia Golan, Tal Sella, Ofer Margalit, Uri Amit, Naama Halpern, Dan Aderka, Einat Shacham-Shmueli, Damien Urban and Yaacov Richard Lawrence

Pages: 1022–1027
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

By: Margaret A. Tempero, Mokenge P. Malafa, Mahmoud Al-Hawary, Horacio Asbun, Andrew Bain, Stephen W. Behrman, Al B. Benson III, Ellen Binder, Dana B. Cardin, Charles Cha, E. Gabriela Chiorean, Vincent Chung, Brian Czito, Mary Dillhoff, Efrat Dotan, Cristina R. Ferrone, Jeffrey Hardacre, William G. Hawkins, Joseph Herman, Andrew H. Ko, Srinadh Komanduri, Albert Koong, Noelle LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Eileen M. O'Reilly, Jorge Obando, Sushanth Reddy, Courtney Scaife, Sarah Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer Burns and Susan Darlow

Pages: 1028–1061
DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development

By: Talia Golan and Milind Javle

Pages: 1063–1069
Trends in Neoadjuvant Approaches in Pancreatic Cancer

By: Lingling Du and Andrea Wang-Gillam

Pages: 1070–1077
Acting on Rare Driver Alterations: Is Getting a Meaningful Response a Game of Chance or Scientific Rigor?

By: David R. Braxton

Pages: 1078–1080